20-Oct-2026 12:23:05

ORCHPHARMA : BOARD APPROVES FUND RAISE OF UP TO RS 600 CR

• Board passed enabling resolution to explore raising up to ₹600 Cr, in the best interest of the company • Route to be equity shares or other eligible securities/instruments including fully or partly convertible debentures • Modes include QIP, private placement, public issue of equity and/or debt, preferential issue or any combination • Fund raise subject to statutory and regulatory approvals, including shareholder approval where applicable • Type of issuance, number of securities and exact amount not finalised as on date

Orchid Pharma Ltd

← Back to feed